Lima, December 19, 2021Updated on 12/19/2021 01:43 pm
Cancer patients 12 years of age and older should come in for their coronavirus booster dose (COVID-19) three months after receiving his second vaccine, reported the Department of Prevention and Control of Cancer of the Ministry of Health (Minsa).
LOOK HERE | COVID-19: Minister of Health on vaccination of children under 11 years: “It does not generate risk”
“There is something important to emphasize and that is that unlike other types of populations, the time of the booster dose, between the second and third, is three months (in cancer patients). They can’t wait the six months as it is in the normal population ”, Víctor Palacios, director of cancer prevention and control of the Minsa, specified in an interview with RPP Noticias.
Regarding the advance of the booster dose to this population group, the official regretted that to date only 29% have received their third vaccine against COVID-19. “The immunity in a patient receiving chemotherapy unfortunately decreases with each session”, he warned.
He also indicated that those patients who receive treatment with the drug rituximab must be evaluated individually by their specialist doctor to authorize vaccination against COVID-19 due to their vulnerable condition.
At another point, the official explained that since the vaccination against COVID-19 began in cancer patients in June 2021, more than 167,000 doses have been applied.
Of this number, 73,122 correspond to first doses and 69,850 to second doses. This last figure is equivalent to 86% of the correctly vaccinated target population.
According to the criteria of